Chief Executive Officer, Novo Nordisk
Appears in 1 story
Defending market position against Lilly's oral entry
For two years, the most effective weight-loss drugs on the market required a weekly injection, but that barrier is now falling. Eli Lilly began shipping Foundayo on April 6, 2026 — just five days after FDA approval in a record 50-day review — making it the first oral GLP-1 pill with no food or water restrictions. At $149/month (or $25 with insurance), it's 85% cheaper than injectables.
Updated May 30
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
